{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:03:09Z","timestamp":1717826589881},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.2169\/internalmedicine.0798-22","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T22:09:56Z","timestamp":1671574196000},"page":"2261-2266","source":"Crossref","is-referenced-by-count":1,"title":["Transthyretin Variant Amyloidosis with a <i>TTR<\/i> A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy"],"prefix":"10.2169","volume":"62","author":[{"given":"Kazuna","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"},{"name":"Department of Neurology, Sunagawa City Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Systems Neuroscience, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Minami Kyoto Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Oka","sequence":"additional","affiliation":[{"name":"Kyoto Konoe Rehabilitation Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaaki","family":"Katoh","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Yazaki","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Shinshu University, Japan"},{"name":"Clinical Laboratory Sciences Division, Shinshu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuki","family":"Kametani","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Institute of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Institute of Neuroscience, and Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Misu K, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan; clinicopathological and genetic features. Brain 122: 1951-1962, 1999.","DOI":"10.1093\/brain\/122.10.1951"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ikeda S, Hanyu N, Hongo M, et al. Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 110: 315-337, 1987.","DOI":"10.1093\/brain\/110.2.315"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36: 411-423, 2007.","DOI":"10.1002\/mus.20821"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62: 1057-1062, 2005.","DOI":"10.1001\/archneur.62.7.1057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orp J Rare Dis 13: 6, 2018.","DOI":"10.1186\/s13023-017-0726-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yamashita T, Ueda M, Misumi Y, et al. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol 265: 134-140, 2018.","DOI":"10.1007\/s00415-017-8640-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Koike H, Sobue G. Diagnosis of familial amyloid polyneuropathy: wide-ranged clinicopathological features. Expert Opin Med Diagn 4: 323-331, 2010.","DOI":"10.1517\/17530059.2010.495384"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- versus late-onset form. Arch Neurol 59: 1771-1776, 2002.","DOI":"10.1001\/archneur.59.11.1771"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Koike H, Misu K, Sugiura M, et al. Pathology of early- vs late- onset TTR Met 30 familial amyloid polyneuropathy. Neurology 63: 129-138, 2004.","DOI":"10.1212\/01.WNL.0000132966.36437.12"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Plant\u00e9-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 69: 693-698, 2007.","DOI":"10.1212\/01.wnl.0000267338.45673.f4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Th\u00e9audin M, Lozeron P, Algarrondo V, et al. Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas. Eur J Neurol 26: 497-e36, 2019.","DOI":"10.1111\/ene.13845"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Koike H, Kawagashira Y, Iijima M, et al. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 255: 1526-1533, 2008.","DOI":"10.1007\/s00415-008-0962-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Abe R, Katoh N, Takahashi Y, et al. Distribution of amyloidosis subtypes based on tissue biopsy site - consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int 71: 70-79, 2021.","DOI":"10.1111\/pin.13041"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Holmgren G, Costa PM, Andersson C, et al. Geographical distribution of TTR Met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 31: 351-354, 1994.","DOI":"10.1136\/jmg.31.5.351"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60: 512-521, 1995.","DOI":"10.1002\/ajmg.1320600606"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 118: 849-856, 1995.","DOI":"10.1093\/brain\/118.4.849"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. JNNP 83: 152-158, 2012.","DOI":"10.1136\/jnnp-2011-301299"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cappellari M, Cavallaro T, Ferrarini M, et al. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst 16: 119-129, 2011.","DOI":"10.1111\/j.1529-8027.2011.00331.x"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Adams D, Lozeron P, Theaudin M, et al. Regional difference and similarity of familial amyloidosis with polyneuropathy in France. Amyloid 19: 61-64, 2012.","DOI":"10.3109\/13506129.2012.685665"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med 79: 733-748, 2012.","DOI":"10.1002\/msj.21352"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chen H, Zhang SM, Hern\u00e1n MA, Willett WC, Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 53: 676-679, 2003.","DOI":"10.1002\/ana.10577"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ikeda S, Yanagisawa N, Hanyu N, Furihata K, Kobayashi T. Coexistence of type I familial amyloid polyneuropathy and spinocerebellar ataxia type 1. Clinical and genetic studies of a Japanese family. JNNP 60: 586-588, 1996.","DOI":"10.1136\/jnnp.60.5.586-a"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Concei\u00e7\u00e3o I, Nzwalo H, de Carvalho M. Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy. Clin Neurol Neurosurg 114: 1355-1357, 2012.","DOI":"10.1016\/j.clineuro.2012.03.023"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rentzs P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47: D886-D894, 2019.","DOI":"10.1093\/nar\/gky1016"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0798-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:27:59Z","timestamp":1715574479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0798-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0798-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"article-number":"0798-22"}}